Wellnex Life Ltd logo

Wellnex Life Ltd(ASX) WNX

Market CapA$5.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-99%
5 YearN/A
1 Year-69%
1 Month-10%
A$0.08
+0.00%
+0.00Today
Wellnex Life Ltd last closing stock price
MetricPriceDate
Last closeAUD 0.082026-10-09
Wellnex Life Ltd stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.32%AUD 0.082026-10-01
1 month-9.64%AUD 0.082026-09-09
3 month+36.36%AUD 0.062026-07-08
Year to date-20.21%AUD 0.092025-12-31
1 year-69.39%AUD 0.252025-10-08
Since inception-98.8%AUD 6.252017-03-15

Wellnex Life Ltd Financials at a Glance

Market Cap

A$5.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$48.46M

Net Income (TTM)

-A$20.15M

EPS (TTM)

-A$0.06

P/E Ratio

-1.18

Dividend

A$0.00

Beta (Volatility)

0.12 (Low)

Price

A$0.08

Volume

97

Open

A$0.08

Previous Close

A$0.08

Daily Range

A$0.08 - A$0.08

52-Week Range

A$0.04 - A$0.24

Estimated Earnings Date

Mar 4, 2027

WNX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Wellnex Life Ltd

Wellnex Life Limited is a health and wellness company focused on developing, marketing, and selling a diverse range of products in Australia, New Zealand, and the United Kingdom. The company offers innovative solutions in the health sector, including topical pain relief and nutritional supplements.

Products and Services
  • Topical anti-inflammatory creams and sprays under the Pain Away brand
  • Caffeine energy capsules and multivitamins under the Wakey Wakey brand
  • Medicinal cannabis products under the Wellness Life brand
Growth Outlook
  • Revenue of AUD 11.9 million reported in the latest quarter
  • Gross profit margin improved to 8.5% in the most recent quarter
  • Strong demand for health products supports future growth potential
Financial Highlights
  • Net income of AUD -2.76 million in the latest quarter
  • Current ratio of 1.46 indicates good short-term financial health
  • Cash and cash equivalents of AUD 862,000 as of the latest quarter
Wellnex Life Limited operates in the packaged foods industry, with a focus on health and wellness products. The company has shown resilience in its revenue generation, with a reported revenue of AUD 11.9 million in the latest quarter, reflecting a steady demand for its offerings. The gross profit margin has also seen an improvement, indicating better cost management and pricing strategies. Despite facing challenges, including a net income loss of AUD 2.76 million, the company maintains a solid current ratio of 1.46, suggesting it can meet its short-term obligations. The cash position of AUD 862,000 provides a buffer for operational needs and potential investments. The growth outlook remains positive, driven by increasing consumer interest in health and wellness products. Wellnex Life Limited's diverse product range positions it well to capitalize on market trends, making it an intriguing option for potential investors interested in the health sector.
AI Generated • Sep 24, 2026

Industry

Food Products

CEO

Zack Bozinovski

Headquarters

Port Melbourne, VIC 3207, AU

WNX Financials

Key Financial Metrics (TTM)

Gross Margin

11.21%

Operating Margin

-8.22%

Net Income Margin

-18.31%

Return on Equity

-52.00%

Return on Capital

-14.19%

Return on Assets

-19.13%

Earnings Yield

-84.75%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$5.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

73.03M

Volume

97

Avg. Volume

89.51K

Financials (TTM)

Gross Profit

A$9.66M

Operating Income

-A$8.66M

EBITDA

-A$7.05M

Operating Cash Flow

-A$3.48M

Capital Expenditure

A$0.00

Free Cash Flow

-A$3.48M

Cash & ST Invst.

A$862.00K

Total Debt

A$9.68M

Wellnex Life Ltd Performance Analysis

Wellnex Life Ltd annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 27,876,00049.8%
20242024-06-30AUD 16,932,000-39.3%
20252025-06-30AUD 23,625,00039.5%
20262026-06-30AUD 24,838,0005.1%
Wellnex Life Ltd sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-316.1%
Q42025-06-30-2.5%
Q22025-12-3110.8%
Q42026-06-30-7.7%
Wellnex Life Ltd annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -1.1940.5%
20242024-06-30AUD -0.73-38.6%
20252025-06-30AUD -0.53-27.2%
20262026-06-30AUD -0.14-73.0%
Wellnex Life Ltd sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-91.3%
Q42025-06-3043.2%
Q22025-12-3189.8%
Q42026-06-30-47.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$11.92M

+5.7%

Gross Profit

A$1.02M

-70.6%

Gross Margin

8.54%

N/A

Market Cap

A$5.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$1.83M

N/A

Employees

3

N/A

Net Income

-A$2.76M

+30.9%

EBITDA

-A$123.00K

+96.9%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$862.00K

-4.5%

Total Debt

A$9.68M

-9.2%

Accounts Receivable

A$2.48M

-43.4%

Inventory

A$367.00K

-89.9%

Long Term Debt

A$0.00

N/A

Short Term Debt

A$9.68M

-9.2%

Return on Assets

-19.13%

N/A

Return on Invested Capital

-27.20%

N/A

Free Cash Flow

A$332.00K

-77.9%

Operating Cash Flow

A$332.00K

+122.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PFT.AXPure Foods Tasmania Limited
A$0.02+0.00%
8IH.AX8I Holdings Limited
A$0.01+0.00%
JAT.AXJatcorp Limited
A$0.09+0.00%
EVE.AXEVE Health Group Limited
A$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$22.18-9.81%
WFFWf
$12.29+499.51%
VZVerizon Communications
$41.65-8.75%
SPCXSpace Exploration Technologies
$162.57+1.25%

Questions About WNX

What is the current price of Wellnex Life Ltd?

Wellnex Life Ltd is trading at A$0.08 per share.

What is the 52-week range for Wellnex Life Ltd?

Over the past 52 weeks, Wellnex Life Ltd has traded between A$0.04 and A$0.24.

How much debt does Wellnex Life Ltd have?

As of the most recent reporting period, Wellnex Life Ltd reported total debt of A$9.68M.

How much cash does Wellnex Life Ltd have on hand?

Wellnex Life Ltd reported A$862.00K in cash and cash equivalents in its most recent financial results.

What is Wellnex Life Ltd’s dividend yield?

Wellnex Life Ltd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.